NCT06318026 Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment
| NCT ID | NCT06318026 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kaiser Permanente |
| Condition | Alcohol Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2025-03-25 |
| Primary Completion | 2029-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,500 participants in total. It began in 2025-03-25 with a primary completion date of 2029-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Systematic Implementation of Patient-centered Care for Alcohol Use Trial is a pragmatic, cluster-randomized, effectiveness-implementation trial testing two interventions in Kaiser Permanente Washington to systematically implement shared decision-making with primary care patients with symptoms due to alcohol use: a primary care intervention and a centralized intervention. An anticipated 25 primary care clinics will be randomized to one of three conditions: usual care or the primary care or centralized interventions.
Eligibility Criteria
Inclusion Criteria: 1. Adult primary care patients ≥18 years old on the day of a primary care appointment; and 2. ≥4 symptoms on the Alcohol Symptom Checklist, or 2-3 symptoms on the Alcohol Symptom Checklist with at least one symptom associated with high risk of progression to severe symptoms, documented in the electronic health record associated with the primary care appointment; and 3. high-risk drinking on the alcohol screening questionnaire (AUDIT-C ≥7) on the day of the Alcohol Symptom Checklist or in the prior 30 days documented in the electronic health record. Exclusion Criteria: 1. Documented request to not participate in research, or 2. Patient was eligible for the Vanguard pilot study.
Contact & Investigator
Katharine Bradley, MD, MPH
PRINCIPAL INVESTIGATOR
Kaiser Permanente
Frequently Asked Questions
Who can join the NCT06318026 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alcohol Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06318026 currently recruiting?
Yes, NCT06318026 is actively recruiting participants. Contact the research team at Katharine.A.Bradley@kp.org for enrollment information.
Where is the NCT06318026 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT06318026 clinical trial?
NCT06318026 is sponsored by Kaiser Permanente. The principal investigator is Katharine Bradley, MD, MPH at Kaiser Permanente. The trial plans to enroll 1,500 participants.